An annual injection designed to guard against Human Immunodeficiency Virus (HIV) has completed an important early safety trial, researchers report in The Lancet medical journal. Lenacapavir stops ...

Advances in care over the last 30 years have helped transform HIV from a fatal disease into a chronic, manageable condition for many people. 1 Innovations in treatment and access are at the core ...

Any donation you make helps us continue our work towards a world where HIV is no longer a threat to health or happiness. £5 allows us to reach millions of people globally with accurate and reliable ...